One BioMed
Manufacturing · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4 Fusionopolis Way Kinesis 06, Singapore...Website
www.onebiomed.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About One BioMed
One BioMed is a molecular life science company based in Singapore, dedicated to advancing human health through innovative biomedical research and testing solutions. Their flagship product, the Xceler8 Solution, is an automated platform for nucleic acid extraction and purification, designed for both research and clinical applications. The company aims to provide biomedical researchers with unprecedented access to cutting-edge tools, thereby accelerating and decentralizing molecular research. With a commitment to transforming lives, One BioMed is positioned at the forefront of innovation in the life sciences sector.Explore more
One BioMed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is One BioMed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if One BioMed had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when One BioMed launches new products
Funding: Get notified immidiatlly once One BioMed has new funding data
Check out if One BioMed is spiking on competitors!
One BioMed, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at One BioMed
Earning: See what the market has to say on One BioMed recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if One BioMed has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined One BioMed as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
One BioMed is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
One BioMed is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about One BioMed.
One BioMed financials insights
Gather financial insights about One BioMed, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$5M
One BioMed Tech Stack
A closer look at the technologies used by One BioMed
One BioMed News & Media
One BioMed Announce World's First Fully Integrated Platform for Automated High Molecular Weight DNA Extraction
Beyond Simple HMW DNA extraction at scale. SINGAPORE, May 22, 2023 /PRNewswire/ -- One BioMed, announced today the launch of the X8™ HMW DNA Cartridge Kits for the automated extraction of high molecular weight DNA for use in long-read sequencing and genome assembly. Inclusive of all the necessary reagents, the X8 HMW DNA Cartridge Kits, powered by the OneTouch Instrument, is the world's first out-of-the-box, automated platform for extraction of HMW DNA from a myriad of sampleOne BioMed launches the cartridge-based Xceler8(TM) Nucleic Acid Extraction Platform, the next generation in workflow simplification
SINGAPORE, Nov. 9, 2021 /PRNewswire/ -- One BioMed, a company focused on advancing human health through innovation, announced today the launch of their Xceler8™ Platform for high-yield extraction and purification of nucleic acids from biological samples. Pre-filled with all the necessary...One BioMed Closes US$5M Series A Funding
One BioMed Pte Ltd, a Singapore-based healthcare startup, closed a US$5M Series A funding round. The round was led by Biopath Ventures and US-based ARCH Venture Partners, with Enterprise Singapore’s investment arm, SEEDS Capital, also participating. The company intends to use the funds to commercialize its first product. Founded by CEO Dr. Mi Kyoung Park […] The post One BioMed Closes US$5M Series A Funding appeared first on FinSMEs.Healthcare Startup One BioMed closes US$5M Series A Funding Round
SINGAPORE, July 10, 2019 /PRNewswire/ -- One BioMed Pte Ltd, a Singapore-based medical diagnostics company, announced today that it has closed a US$5 million Series A financing round, led by Singapore-based Biopath Ventures and US-based ARCH Venture Partners, with Enterprise Singapore's...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding One BioMed
Sign Up For FreeTo access detailed company insights
One BioMed is a molecular life science company based in Singapore, dedicated to advancing human health through innovative biomedical research and testing solutions. Their flagship product, the Xceler8 Solution, is an automated platform for nucleic acid extraction and purification, designed for both research and clinical applications. The company ai... Read More
